Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Soares, Emerson Wander S ^a,b   Nagai, Hildebrando M ^c   Bredt, Luis C ^c   da Cunha Jr, Ademar D ^c   Andrade, Reginaldo J ^c   Soares, Géser Vinícius S ^c  

^a UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^b Study and Treatment Cancer Center of Western Paraná   (Brazil)

^c UOPECCAN   (Brazil)

Author keywords

Axillary lymph node metastases; Invasive breast cancer; Lymphedema; Postsurgical complications

Indexed keywords

ABDUCTION; ADULT; AGE DISTRIBUTION; ARM CIRCUMFERENCE; ARM PAIN; ARTICLE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEMATOMA; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; MOTOR DYSFUNCTION; PARESTHESIA; PARTIAL MASTECTOMY; PERIMETRY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREVALENCE; RANGE OF MOTION; RANGE OF MOTION RESTRICTION; SEROMA;

AXILLA; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHEDEMA; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MORBIDITY; PAIN, POSTOPERATIVE; PARESTHESIA; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RANGE OF MOTION, ARTICULAR;

EID: 84899132158     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-67     Document Type: Article

References (38)

1. National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 2 2013, http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf, National Comprehensive Cancer Network.
2. AJCC Breast. AJCC Cancer Staging Manual 2010, 347-376. New York, NY: Springer, Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, 7, AJCC.
3. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011, 305:569-575. 10.1001/jama.2011.90, 21304082.
4. Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol 2008, 15:1996-2005. 10.1245/s10434-008-9909-y, 18415650.
5. McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol 2008, 26:5220-5226. 10.1200/JCO.2008.16.3766, 2652092, 18838708.
6. Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecoraro P, Belardinelli V, De Salvo GL GIVOM Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 2008, 34:508-513. 10.1016/j.ejso.2007.05.017, 17614245, GIVOM.
7. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006, 95:279-293. 10.1007/s10549-005-9025-7, 16163445.
8. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) 2009, Bethesda, MD: National Cancer Institute, http://seer.cancer.gov/statfacts/html/breast.html.
9. Ministério Da Saúde - Instituto Nacional Do Câncer José Alencar Gomes Da Silva (INCA). Coordenação-Geral de Ações Estratégicas. Coordenação de Prevenção e Vigilância (Conprev) [Department Of Health - National Cancer Institute José Alencar Gomes Da Silva (INCA) Informativo Vigilância do Câncer n.2 2012, Brasilia: Ministério Da Saúde, http://www1.inca.gov.br/inca/Arquivos/comunicacao/informativo_vigilancia_cancer_n2_2012_internet.pdf, Ministério Da Saúde - Instituto Nacional Do Câncer José Alencar Gomes Da Silva (INCA). Coordenação-Geral de Ações Estratégicas. Coordenação de Prevenção e Vigilância (Conprev) [Department Of Health - National Cancer Institute José Alencar Gomes Da Silva (INCA).
10. Berg JW. The significance of axillary node levels in the study of breast carcinoma. Cancer 1955, 8:776-778. 10.1002/1097-0142(1955)8:4<776::AID-CNCR2820080421>3.0.CO;2-B, 13240660.
11. Zarebczan DB, Neuman HB. Management of the axilla. Surg Clin North Am 2013, 93:429-444. 10.1016/j.suc.2012.12.008, 23464694.
12. Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G, Winer EP. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 1998, 83:1362-1368. 10.1002/(SICI)1097-0142(19981001)83:7<1362::AID-CNCR13>3.0.CO;2-2, 9762937.
13. Halsted WS. I. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907, 46:1-19.
14. Patey DH, Dyson WH. The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Cancer 1948, 2:7-13. 10.1038/bjc.1948.2, 2007539, 18863724.
15. Auchincloss H. Significance of location and number of axillary metastases in carcinoma of the breast. Ann Surg 1963, 158:37-46. 10.1097/00000658-196307000-00008, 1408351, 14042633.
16. Madden JL. Modified radical mastectomy. Surg Gynecol Obstet 1965, 121:1221-1230.
17. Pesce C, Morrow M. The need for lymph node dissection in nonmetastatic breast cancer. Annu Rev Med 2013, 64:119-129. 10.1146/annurev-med-052511-135500, 23020881.
18. Olaya W, Wong J, Wong J, Morgan J, Kazanjian K, Lum S. When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections. Ann Surg Oncol 2013, 20:627-632. 10.1245/s10434-012-2642-6, 22956069.
19. Schunemann H, Willich N. Lymphodeme nach mammakarzinom [Lymphedema after breast cancer]. Dtsch Med Wochenschr 1997, 122:536-541. 10.1055/s-2008-1047650, 9190300.
20. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013, 14:500-515. 10.1016/S1470-2045(13)70076-7, 23540561.
21. Meek AG. Breast radiotherapy and lymphedema. Cancer 1998, 83:2788-2797. 10.1002/(SICI)1097-0142(19981215)83:12B+<2788::AID-CNCR27>3.0.CO;2-I, 9874399.
22. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003, 349:546-553. 10.1056/NEJMoa012782, 12904519.
23. Moore MP, Kinne DW. Axillary lymphadenectomy: a diagnostic and therapeutic procedure. J Surg Oncol 1997, 66:2-6. 10.1002/(SICI)1096-9098(199709)66:1<2::AID-JSO2>3.0.CO;2-8, 9290685.
24. Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med 2007, 356:2399-2405. 10.1056/NEJMra065241, 17554121.
25. Harris J, Ostenn R. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985, 5:17-21. 10.1007/BF01807645, 3978244.
26. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30. 10.3322/caac.21166, 23335087.
27. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232. 10.1056/NEJMoa020989, 12393819.
28. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241. 10.1056/NEJMoa022152, 12393820.
29. Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med 2000, 343:1086-1094. 10.1056/NEJM200010123431506, 11027744.
30. Keramopoulos A, Tsionou C, Minaretzis D, Michalas S, Aravantinos D. Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 1993, 50:445-449. 10.1159/000227227, 8233285.
31. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992, 69:2496-2501. 10.1002/1097-0142(19920515)69:10<2496::AID-CNCR2820691018>3.0.CO;2-T, 1568171.
32. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 1992, 28:1415-1418.
33. Salmon RJ, Ansquer Y, Asselain B. Preservation versus section of intercostal-brachial nerve (IBN) in axillary dissection for breast cancer - a prospective randomized trial. Eur J Surg Oncol 1998, 24:158-161. 10.1016/S0748-7983(98)92793-7, 9630850.
34. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, Skelly JM, Harlow SP, Weaver DL, Mamounas EP, Costantino JP, Wolmark N National Surgical Adjuvant Breast, Bowel Project Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010, 102:111-118. 10.1002/jso.21535, 3072246, 20648579, National Surgical Adjuvant Breast, Bowel Project.
35. Kootstra JJ, Dijkstra PU, Rietman H, de Vries J, Baas P, Geertzen JH, Hoekstra HJ, Hoekstra-Weebers JE. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection. Breast Cancer Res Treat 2013, 139:125-134. 10.1007/s10549-013-2509-y, 23588950.
36. Luttgens K, Hamilton N. Kinesiology: scientific basis of human motion 1997, Brown & Benchmark: Madison, WI, 9.
37. Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JW, Crommelin MA, Luiten EJ, van Repelaer DOJ, Schijven M, Wissing JC, Voogd AC. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001, 37:991-999. 10.1016/S0959-8049(01)00067-3, 11334724.
38. Hayes S, Battistutta D, Newman B. Objective and subjective upper body function six months following diagnosis of breast cancer. Breast Cancer Res Treat 2005, 94:1-10. 10.1007/s10549-005-5991-z, 16172793.